/

Investors / United States / 82VS

82VS

Investor · Waltham, MA, United States · North America

82vs.comTakes pitches from founders

82VS is a venture studio that builds asset-focused drug companies, providing them access to Alloy Therapeutics' discovery platforms and services across antibodies, bispecifics, TCR mimics, and genetic medicines. It supports company creation from concept to Series A with strategy, legal services, R&D funding, and partnerships.

Invests inHealthcare & Biotech

In its own wordsbiotechdrug discoveryventure studioantibodiesgenetic medicinestherapeutics

Your fit with 82VS

Four questions about your startup

See how your round matches what it backs, point by point.

Or find every investor that fits
5portfolio companies
0funding rounds on record
Series Astages it states

82VS lists 5 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 50% of its companies are based in United Kingdom. It invests most often alongside BaseCamp Ventures, Dragon Global and Draper Associates.

No funding round on record names 82VS yet, so the figures come from its portfolio page.

Investor profile

percentile among all firms
Portfolio size: 5 companiesRecent activity: 0 rounds in 12 monthsEarly stage: 0% of entries at pre-seed or seedEvidence: 0% of companies confirmed by a roundSector focus: 100% in its largest sectorReach: 2 countriesPortfolio size4th pctRecent activity46th pctEarly stage54th pctEvidence52th pctSector focus100th pctReach42th pct
This firmMedian of all firms
Show as a table
82VS compared with all firms
MeasurePercentile of all firmsValue
Portfolio size4th5 companies
Recent activity46th0 rounds in 12 months
Early stage54th0% of entries at pre-seed or seed
Evidence52th0% of companies confirmed by a round
Sector focus100th100% in its largest sector
Reach42th2 countries

Its portfolio companies

where they are based, and what their own sites show

Headquarters

Site status

  • Site answers5100%
  • No longer answers00%
  • Points to another company00%
  • Parked or sold domain00%

A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.

Investment themes

share of its checked companies

This firmAll checked companies

Show as a table
Investment themes
This firmAll checked companies
Healthcare & Biotech100%15%

Co-investor network

who it backs companies with, and who they back together
4 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companies2 shared companiesBaseCamp Ventures: 1 shared companiesBaseCamp Ventures1Dragon Global: 1 shared companiesDragon Global1Draper Associates: 1 shared companiesDraper Associates1Evolution-VC: 1 shared companiesEvolution-VC1Idealab: 1 shared companiesIdealab1Khosla Ventures: 1 shared companiesKhosla Ventures1Octopus Ventures: 1 shared companiesOctopus Ventures1Overwater Ventures: 1 shared companiesOverwater Ventures1Wisdom Ventures: 1 shared companiesWisdom Ventures1
Shared portfolio companies with 82VSFirms that also back companies together

All co-investors or Compare portfolios with BaseCamp Ventures

Compare 82VS head to head

portfolio size, rounds, entry stages, themes and the companies both back

Three or more firms at once: portfolio overlap.

Portfolio

5 companies checked against their own sites
CompanyWhat it doesThemesFirst round with itEvidence
Aakha Biologicsaakha.bioAakha Biologics is developing new treatments for patients with limited options by creating first-in-class, multi-specific antibodies for solid tumors.
Healthcare & Biotech
Portfolio page
Broadwing Biobroadwing.bioThe company is advancing antibody therapies to treat major causes of adult vision loss.
Healthcare & Biotech
Portfolio page
Cantaicantaitx.com · United KingdomCantai builds high-value, rationally designed bispecific antibodies that combine clinically validated mechanisms to achieve superior outcomes for patients with autoimmune disease.
Healthcare & Biotech
Portfolio page
Overtureoverture.lifeOverture Life develops and provides automated fertility treatment technology and products
Healthcare & Biotech
Portfolio page
Vorovorotx.com · United StatesVoro Therapeutics is a biotechnology company that develops tumor-activated biologics for cancer treatment.
Healthcare & Biotech
Portfolio page

About this data

site last read 5 Nov 2026
The homepage of 82VS, as last read
82vs.com as VCinfo last read it
Site
82vs.com
Last read
5 Nov 2026
Watching since
6 Nov 2026
Companies checked
5

Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.

How we grade the data

Free account · no card

Get 82VS' profile as data

Pull 82VS' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.

Work email, sign-in link by email. Already have an account? Log in
  • Ask AI5 plain-English investor searches a day
  • Full listsEvery portfolio row and two-firm overlap
  • API and MCP100 REST or MCP calls a month, one key
  • AlertsFollow 5 investors for portfolio and fund changes
VCinfo API
$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/82vs.com

# also
GET /v1/firms/82vs.com/portfolio
GET /v1/firms/82vs.com/coinvestors
GET /v1/firms/82vs.com/news
The same data as an MCP server for Claude, Cursor and other AI tools. Set up MCP · Docs · Pricing